-+ 0.00%
-+ 0.00%
-+ 0.00%

CJ Cheiljedang signs joint venture deal with ADM for global feed amino acids business

PUBT·10/02/2026 08:53:08
Listen to the news
CJ Cheiljedang signs joint venture deal with ADM for global feed amino acids business
  • CJ Cheiljedang signed a contribution agreement with ADM to form a US joint venture in global feed amino acids.
  • Equity split set at 63% for CJ Bio America, 37% for ADM.
  • Transaction moves CJ’s feed amino acid operations, including Mexico and Brazil units, into the new venture via in-kind contributions.
  • Structure targets stronger competitiveness in feed amino acids, improved raw material sourcing stability.
  • Agreement signed Oct. 2, 2026; terms remain subject to regulatory approvals, including merger filings.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CJ Cheiljedang Corporation published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261002800947), on October 02, 2026, and is solely responsible for the information contained therein.